CNS Pharmaceuticals(CNSP) - 2024 Q1 - Quarterly Report

FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ______________ Nevada 82-2318545 (State or other jurisdiction of Incorporation or Organization) (I.R.S. Employer identification No.) Title of Each Class Trading Symbol Name of Each Exchange on Which Registered Common Stock CNSP The NASDAQ Stock Market LLC If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended ...